Pingfei Li
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Automotive Engineering top 10%
- Additive Manufacturing and 3D Printing Technologies
Papers in
-
- Glycosylation and Glycoproteins Research 2
-
- Drug Solubulity and Delivery Systems 6
- Co-authors
- Weisan Pan (12 shared papers)Xinggang Yang (10 shared papers)Mengsuo Cui (6 shared papers)Haoyang Wen (4 shared papers)Xiang‐Ping Yang (9 shared papers)Shiming Zhang (4 shared papers)Zhengping Wei (8 shared papers)Yining Yang (3 shared papers)
- Journals
- AAPS PharmSciTech (4 papers)Journal of Drug Delivery Science and Technology (2 papers)Vaccine (2 papers)Scientific Reports (2 papers)Drug Delivery (1 paper)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Pingfei Li
31 papers receiving 598 citations
Peers
Comparison fields: 5 of 91
- Pharmaceutical Science 121
- Automotive Engineering 125
- Molecular Medicine 30
- Hepatology 33
- Biomedical Engineering 197
Countries citing papers authored by Pingfei Li
This map shows the geographic impact of Pingfei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pingfei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pingfei Li more than expected).
Fields of papers citing papers by Pingfei Li
This network shows the impact of papers produced by Pingfei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pingfei Li. The network helps show where Pingfei Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Pingfei Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 50 | |
| 2 | 2018 | 47 | |
| 3 | 2017 | 43 | |
| 4 | 2018 | 42 | |
| 5 | 2007 | 37 | |
| 6 | 2017 | 36 | |
| 7 | 2019 | 32 | |
| 8 | 2019 | 30 | |
| 9 | 2019 | 28 | |
| 10 | 2018 | 24 | |
| 11 | 2021 | 24 | |
| 12 | 2021 | 21 | |
| 13 | 2006 | 20 | |
| 14 | 2024 | 20 | |
| 15 | 2016 | 20 | |
| 16 | 2019 | 18 | |
| 17 | 2019 | 18 | |
| 18 | 2022 | 18 | |
| 19 | 2017 | 17 | |
| 20 | 2007 | 14 |
About Pingfei Li
Pingfei Li is a scholar working on Molecular Biology, Pharmaceutical Science, Biomedical Engineering, Immunology and Food Science, having authored 31 papers that have together received 615 indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (6 papers), 3D Printing in Biomedical Research (5 papers), Polysaccharides and Plant Cell Walls (4 papers), Immune Cell Function and Interaction (3 papers), Additive Manufacturing and 3D Printing Technologies (3 papers), Glycosylation and Glycoproteins Research (2 papers), Galectins and Cancer Biology (2 papers) and Microencapsulation and Drying Processes (2 papers). The work is most often cited by research in Pharmaceutical Science (121 citations), Automotive Engineering (125 citations), Molecular Medicine (30 citations), Hepatology (33 citations) and Biomedical Engineering (197 citations). Pingfei Li has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Weisan Pan, Xinggang Yang, Mengsuo Cui, Haoyang Wen, Xiang‐Ping Yang, Shiming Zhang, Zhengping Wei, Yining Yang, Shu Wang and Fen Chen. Their work appears in journals such as AAPS PharmSciTech, Journal of Drug Delivery Science and Technology, Vaccine, Scientific Reports and Drug Delivery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.